Bristol-Myers Squibb Company
BMY
$48.84
$0.3750.77%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 188.14% | -211.50% | -187.60% | -182.14% | -184.09% |
| Total Depreciation and Amortization | -21.69% | -1.26% | 4.89% | 1.43% | -1.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -80.04% | 778.71% | 709.52% | 531.85% | 643.68% |
| Change in Net Operating Assets | -253.65% | 142.32% | 112.05% | 69.38% | 88.97% |
| Cash from Operations | 4.27% | 9.60% | 16.18% | 19.52% | 12.27% |
| Capital Expenditure | -0.74% | -3.23% | 2.04% | -7.79% | -6.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 91.27% | -1,766.64% | -3,075.43% | -513.71% | -439.11% |
| Divestitures | 19.28% | 20.90% | -26.98% | -26.16% | -31.68% |
| Other Investing Activities | 1.12% | 174.82% | -94.35% | -107.02% | -111.38% |
| Cash from Investing | 89.71% | -830.37% | -8,623.48% | -1,512.86% | -1,487.64% |
| Total Debt Issued | -98.11% | 258.45% | 5,481.57% | 6,574.59% | 7,142.86% |
| Total Debt Repaid | -148.96% | -46.86% | -325.39% | -12.48% | 67.69% |
| Issuance of Common Stock | -- | -- | 1,150.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | 3.75% | -50.88% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.13% | -2.51% | -1.61% | -1.88% | -2.48% |
| Other Financing Activities | -2,140.00% | -- | -148.60% | -133.16% | -100.89% |
| Cash from Financing | -226.96% | 154.45% | 156.76% | 149.40% | 157.65% |
| Foreign Exchange rate Adjustments | -100.00% | -404.44% | 41.94% | -179.41% | 55.17% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 438.81% | -153.42% | 183.55% | 16.02% | 108.10% |